Novo Nordisk's Wegovy sales exceed expectations in Q3, driven by strong demand for the weight management treatment. The company's quarterly earnings report shows a significant increase in revenue from the medication.

Source: https://www.bloomberg.com/news/articles/2024-11-06/novo-nordisk-s-wegovy-sales-exceed-expectations-in-third-quarter